419 related articles for article (PubMed ID: 33198323)
1. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
[TBL] [Abstract][Full Text] [Related]
2. Glycoproteins and glycoproteomics in pancreatic cancer.
Pan S; Brentnall TA; Chen R
World J Gastroenterol; 2016 Nov; 22(42):9288-9299. PubMed ID: 27895417
[TBL] [Abstract][Full Text] [Related]
3. Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer.
Islam Khan MZ; Tam SY; Law HKW
Cells; 2022 Mar; 11(6):. PubMed ID: 35326424
[TBL] [Abstract][Full Text] [Related]
4. Molecular Detection of Gastrointestinal Neoplasia: Innovations in Early Detection and Screening.
Anderson BW; Ahlquist DA
Gastroenterol Clin North Am; 2016 Sep; 45(3):529-42. PubMed ID: 27546847
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of cancer tissues: shedding light on carcinogenesis and possible biomarkers.
Kuramitsu Y; Nakamura K
Proteomics; 2006 Oct; 6(20):5650-61. PubMed ID: 16972299
[TBL] [Abstract][Full Text] [Related]
6. piRNA: A promising biomarker in early detection of gastrointestinal cancer.
Ameli Mojarad M; Ameli Mojarad M; Shojaee B; Nazemalhosseini-Mojarad E
Pathol Res Pract; 2022 Feb; 230():153757. PubMed ID: 34998210
[TBL] [Abstract][Full Text] [Related]
7. Glycoproteomic contributions to hepatocellular carcinoma research: a 2023 update.
Zheng Y; Gao K; Gao Q; Zhang S
Expert Rev Proteomics; 2023; 20(10):211-220. PubMed ID: 37882248
[TBL] [Abstract][Full Text] [Related]
8. Proximal fluid proteomics for the discovery of digestive cancer biomarkers.
Farina A
Biochim Biophys Acta; 2014 May; 1844(5):988-1002. PubMed ID: 24184935
[TBL] [Abstract][Full Text] [Related]
9. The current state of proteomics in GI oncology.
Lin Y; Dynan WS; Lee JR; Zhu ZH; Schade RR
Dig Dis Sci; 2009 Mar; 54(3):431-57. PubMed ID: 19104933
[TBL] [Abstract][Full Text] [Related]
10. Proteomics for discovery of candidate colorectal cancer biomarkers.
Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
[TBL] [Abstract][Full Text] [Related]
11. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
Coleman O; Henry M; McVey G; Clynes M; Moriarty M; Meleady P
Expert Rev Proteomics; 2016; 13(4):383-94. PubMed ID: 26985644
[TBL] [Abstract][Full Text] [Related]
12. Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology.
Fernandes E; Sores J; Cotton S; Peixoto A; Ferreira D; Freitas R; Reis CA; Santos LL; Ferreira JA
Theranostics; 2020; 10(11):4903-4928. PubMed ID: 32308758
[TBL] [Abstract][Full Text] [Related]
13. Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma.
Norton P; Comunale MA; Herrera H; Wang M; Houser J; Wimmerova M; Romano PR; Mehta A
Proteomics; 2016 Dec; 16(24):3126-3136. PubMed ID: 27650323
[TBL] [Abstract][Full Text] [Related]
14. Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers.
Dai Z; Zhou J; Qiu SJ; Liu YK; Fan J
Electrophoresis; 2009 Sep; 30(17):2957-2966. PubMed ID: 19711376
[TBL] [Abstract][Full Text] [Related]
15. Biomarker discovery and validation for gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancers.
Hakami ZH
Pathol Res Pract; 2024 Mar; 255():155216. PubMed ID: 38401376
[TBL] [Abstract][Full Text] [Related]
16. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.
Albulescu R; Neagu M; Albulescu L; Tanase C
Expert Rev Mol Diagn; 2011 Jan; 11(1):101-20. PubMed ID: 21171925
[TBL] [Abstract][Full Text] [Related]
17. Perspectives of clinical proteomics in gastrointestinal cancer.
Ebert M; Xing X; Burgermeister E; Schmid R; Röcken C
Expert Rev Anticancer Ther; 2007 Apr; 7(4):465-9. PubMed ID: 17428167
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer.
Ger M; Kaupinis A; Petrulionis M; Kurlinkus B; Cicenas J; Sileikis A; Valius M; Strupas K
Anticancer Res; 2018 Oct; 38(10):5759-5765. PubMed ID: 30275197
[TBL] [Abstract][Full Text] [Related]
19. Proteome-based biomarkers in pancreatic cancer.
Sun C; Rosendahl AH; Ansari D; Andersson R
World J Gastroenterol; 2011 Nov; 17(44):4845-52. PubMed ID: 22171124
[TBL] [Abstract][Full Text] [Related]
20. [Research advances in application of isobaric tags for relative and absolute quantitation in proteomics of hepatocellular carcinoma].
Qi YZ; Chen LS; Xu P
Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):952-955. PubMed ID: 28073423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
